OBIO Pre-CAAP Company: Proteocyte Announces Changes to Board of Directors for 2018
Proteocyte Diagnostics, a company that has designed a platform technology to predict your risk of developing cancer, announces the restructuring and expansion of the Board of Directors with the addition of James Appleyard, Laurence Hicks, Peter G. Schulam and Carlo Sistilli. Proteocyte is also pleased to announce that Robert Lawrie, the Chair of the Canadian Cancer Society, has agreed to join the Board.